Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.
The mechanism of disease progression in Hashimoto's thyroiditis (HT) is still unclear. Anti-thyroid peroxidase antibody (TPOAb), a diagnostic hallmark of HT, is principally of the immunoglobulin G (IgG) isotype, and it appears to be a response to thyroid injury. The aim of our study was to evaluate the distribution of IgG subclasses of TPOAb in sera from patients with HT with different thyroid functional status. Sera from 168 patients with newly diagnosed HT were collected and divided into three groups according to thyroid function: patients with hypothyroidism (n = 66), subclinical hypothyroidism (n = 60) and euthyroidism (n = 42). Antigen-specific enzyme-linked immunosorbent assay was used to detect the distribution of TPOAb IgG subclasses. The prevalence of TPOAb IgG subclasses in all patients' sera with HT was IgG1 70.2%, IgG2 35.1%, IgG3 19.6% and IgG4 66.1% respectively. The prevalence of IgG2 in sera from patients with hypothyroidism (51.5%) was significantly higher than that of subclinical hypothyroidism (33.3%) (P < 0.05), and the latter was also significantly higher than that of euthyroidism (11.9%) (P < 0.05). The positive percentage of IgG2 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism (P < 0.05), the prevalence and positive percentage of IgG4 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism respectively (P < 0.05). The predominant TPOAb IgG subclasses in sera from patients with HT were IgG1 and IgG4. Patients with high levels of TPOAb IgG2, IgG4 subclasses might be at high risk of developing overt hypothyroidism.
Xie
L-D
LD
Department of Endocrinology, Peking University First Hospital, Beijing, China.
Gao
Y
Y
Li
M-R
MR
Lu
G-Z
GZ
Guo
X-H
XH
D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D050031:Hashimoto Disease / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood*; D007453:Iodide Peroxidase / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013961:Thyroid Gland / Q000276:immunology / Q000503:physiopathology*; D013972:Thyrotropin / Q000097:blood
D001323:Autoantibodies; D015415:Biomarkers; D007074:Immunoglobulin G; D013972:Thyrotropin; D007453:Iodide Peroxidase
Horm Res. 2003;59(3):118-24
12637791
Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68
7641412
Eur J Endocrinol. 1995 Jan;132(1):69-74
7850011
Mol Immunol. 1985 Mar;22(3):161-206
3889592
Clin Endocrinol (Oxf). 1987 Mar;26(3):335-46
3652478
Scand J Immunol. 1989 Jul;30(1):73-82
2756340
J Clin Endocrinol Metab. 1997 Mar;82(3):925-31
9062508
N Engl J Med. 1996 Jul 11;335(2):99-107
8649497
J Exp Med. 1987 Nov 1;166(5):1351-61
3500259
J Immunol. 1994 Dec 1;153(11):4948-58
7963558
Nature. 1988 Apr 21;332(6166):738-40
3258649
J Clin Endocrinol Metab. 1996 Jul;81(7):2595-600
8675583
Neuroimmunomodulation. 2004;11(4):209-13
15249726
Ann Allergy. 1987 Feb;58(2):89-96, 99
3544971
J Clin Endocrinol Metab. 1993 Dec;77(6):1700-5
7903315
Clin Exp Immunol. 1986 Jan;63(1):73-9
3485488
Autoimmunity. 1989;4(4):247-54
2491649
J Clin Endocrinol Metab. 2002 Apr;87(4):1754-61
11932312
Annu Rev Immunol. 1989;7:407-44
2469440
Clin Exp Immunol. 1984 Jul;57(1):239-43
6430614
Mol Immunol. 1992 Mar;29(3):319-26
1557042
J Clin Endocrinol Metab. 1994 Aug;79(2):395-400
8045954
J Clin Endocrinol Metab. 1986 May;62(5):945-9
2420816
Eur J Endocrinol. 2003 Apr;148(4):383-8
12656657